Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit

被引:27
作者
Delmas, A. [1 ]
Gordien, J. B. [1 ]
Bernadou, J. M. [1 ]
Roudaut, M. [1 ]
Gresser, A. [1 ]
Malki, L. [1 ]
Saux, M. C. [1 ,2 ,3 ]
Breilh, D. [1 ,2 ,3 ]
机构
[1] CHU Bordeaux, Pharm Hop Haut Leveque, Pessac, France
[2] Univ Bordeaux 2, Lab Pharmacocinet Clin, EA2968, Bordeaux, France
[3] Univ Bordeaux 2, Pharm Clin, Grp PK PD, Bordeaux, France
关键词
Cytotoxic; Control; HPLC-UV; Quality assurance; Diode array detection; DRUG-RELATED PROBLEMS; ASSURANCE; ERRORS;
D O I
10.1016/j.jpba.2009.03.007
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The constantly growing incidence of cancer and long-term treatment are leading to an increasing number of cytotoxic preparations in hospital pharmacies. Security and quality standards of cytotoxic preparations are essential to assure treatment efficiency and limit iatrogenic toxicity. In order to secure the process of cytotoxic preparations; we decided to install a quantitative and qualitative High Performance Liquid Chromatography (HPLC) control of cytotoxic preparations carried inside our pharmacotechnic unit. A 100 mu l sample of each preparation was assayed by HPLC with ultraviolet/visible-diode array detection, which enabled the identification of all cytotoxic agents thanks to their characteristic UV spectra. We developed rapid and specific HPLC assays that determined qualitatively and quantitatively the presence of 21 different cytotoxic agents in less than 3.5 min. A fifteen per cent tolerance from the theoretical concentration was chosen in agreement with preparation and dosage bias, and a first period control of more than 4400 preparations revealed that around 7.7% preparations did not conform. The main objective of these controls was to avoid the administration of defective chemotherapies to patients and finally to use their results to identify error factors; as a result we will take corrective measures in order to reduce error frequency. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:1213 / 1220
页数:8
相关论文
共 15 条
[1]   ETOPOSIDE AS A QUALITY INDICATOR [J].
BEAUPIN, CM ;
DARMANADEN, R .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) :650-650
[2]   Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy [J].
Borget, Isabelle ;
Laville, Isabelle ;
Paci, Angelo ;
Michiels, Stefan ;
Mercier, Lionel ;
Desmaris, Romain-Pacome ;
Bourget, Philippe .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (01) :92-98
[3]   Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit [J].
Bourget, P ;
Paci, A ;
Rey, JB ;
Mercier, L ;
Demirdjian, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (03) :445-451
[4]   Errors evolution and analysis in antineoplastic drug preparation during one year. [J].
Escoms, MC ;
Cabanas, MJ ;
Oliveras, M ;
Hidalgo, E ;
Barroso, C .
PHARMACY WORLD & SCIENCE, 1996, 18 (05) :178-181
[5]  
Havard L., 2005, STP PHARM PRAT, V15, P148
[6]   Is HPLC assay for drug substance a useful quality control attribute? [J].
Hofer, Jeffrey D. ;
Olsen, Bernard A. ;
Rickard, Eugene C. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 44 (04) :906-913
[7]  
International Conference on Harmonization (ICH), 2005, Q2 (R1): Text on Validation of Analytical Procedures
[8]  
SANCO. Guidance Document Onanalytical Quality Control and Validation Procedures for Pesticide Residues Analysis in Food and Feed
[9]  
Krähenbühl-Melcher A, 2007, DRUG SAFETY, V30, P379
[10]   Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit [J].
Limat, S ;
Drouhin, JP ;
Demesmay, K ;
Tissot, E ;
Jacquet, M ;
Woronoff-Lemsi, MC .
PHARMACY WORLD & SCIENCE, 2001, 23 (03) :102-106